Ensuring access and affordability through COVID-19 vaccine research and development investments: A proposal for the options market for vaccines

Vaccine. 2020 Sep 3;38(39):6075-6077. doi: 10.1016/j.vaccine.2020.07.068. Epub 2020 Jul 31.

Authors

Rebecca Forman¹, Michael Anderson², Mark Jit³, Elias Mossialos⁴

Affiliations

¹ London School of Economics and Political Science, London, UK. Electronic address: r.m.forman@lse.ac.uk.
² London School of Economics and Political Science, London, UK.
³ London School of Hygiene and Tropical Medicine, London, UK.
⁴ London School of Economics and Political Science, London, UK; Imperial College London, London, UK.

Abstract

•
Currently, unconditional investment is being made into COVID-19 vaccine R&D COVID-19 vaccine R&D investments should also ensure access and affordability.
•
The options market for antibiotics, could be adapted for use with COVID-19 vaccines.
•
This could help fund R&D, boost manufacturing capacity and secure fair prices.
•
Further research on the OMV model in the current COVID-19 crisis is warranted.

Keywords: Covid19; Health policy; Innovative financing mechanisms; Manufacturing capacity; Research and development.

MeSH terms

Betacoronavirus / pathogenicity
COVID-19
COVID-19 Vaccines
Coronavirus Infections / economics
Coronavirus Infections / epidemiology
Coronavirus Infections / immunology
Coronavirus Infections / prevention & control*
Coronavirus Infections / virology
Costs and Cost Analysis
Drug Approval / organization & administration*
Drug Industry / economics*
Drug Industry / ethics
Financing, Government / statistics & numerical data
Government Regulation
Health Services Accessibility / organization & administration
Humans
Pandemics / prevention & control*
Pneumonia, Viral / epidemiology
Pneumonia, Viral / immunology
Pneumonia, Viral / prevention & control*
Pneumonia, Viral / virology
SARS-CoV-2
United Kingdom / epidemiology
Viral Vaccines / biosynthesis
Viral Vaccines / economics*

Substances

COVID-19 Vaccines
Viral Vaccines